project id: TCGA-UCEC; case submitter id: TCGA-B5-A0JN; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.3; spectrophotometer method: UV Spec; age at index: 84; days to birth: -30933; ethnicity: not reported; gender: female; race: black or african american; vital status: Alive; year of birth: 1920; age at diagnosis: 30933; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1939.0; figo stage: Stage IVB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: Not Reported; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2164; days to sample procurement: 0; initial weight: 440.0; portion submitter id: TCGA-B5-A0JN-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0;